Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types

Longfa Kou,Yangzom D. Bhutia,Qing Yao,Zhonggui He,Jin Sun,Vadivel Ganapathy

DOI: https://doi.org/10.3389/fphar.2018.00027

IF: 5.6

2018-01-26

Frontiers in Pharmacology

Abstract:Targeted nano-drug delivery systems conjugated with specific ligands to target selective cell-surface receptors or transporters could enhance the efficacy of drug delivery and therapy. Transporters are expressed differentially on the cell-surface of different cell types, and also specific transporters are expressed at higher than normal levels in selective cell types under pathological conditions. They also play a key role in intestinal absorption, delivery via non-oral routes (e.g., pulmonary route and nasal route), and transfer across biological barriers (e.g., blood-brain barrier and blood-retinal barrier. As such, the cell-surface transporters represent ideal targets for nano-drug delivery systems to facilitate drug delivery to selective cell types under normal or pathological conditions and also to avoid off-target adverse side effects of the drugs. There is increasing evidence in recent years supporting the utility of cell-surface transporters in the field of nano-drug delivery to increase oral bioavailability, to improve transfer across the blood-brain barrier, and to enhance delivery of therapeutics in a cell-type selective manner in disease states. Here we provide a comprehensive review of recent advancements in this interesting and important area. We also highlight certain key aspects that need to be taken into account for optimal development of transporter-assisted nano-drug delivery systems.

pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to direct the delivery of nanoparticles through cell - surface transporters in order to enhance the ability of drugs to penetrate cell barriers and the drug exposure to specific cell types. Specifically, the research focuses on using specific cell - surface transporters as targets to design and optimize nanoparticle - based drug - delivery systems that can bind to these transporters, thereby achieving:

1. **Enhancing the ability of drugs to penetrate cell barriers**: For example, penetrating the blood - brain barrier (BBB) or the intestinal absorption barrier, which is especially important for treating brain diseases or improving the bioavailability of oral drugs.
2. **Increasing the selective drug exposure to specific cell types**: By targeting transporters highly expressed on the surface of specific cells, non - target side effects of drugs can be reduced and the therapeutic effect can be improved.

To achieve the above - mentioned goals, researchers have explored the characteristics of different transporters and their expression in different tissues and pathological conditions, and analyzed how the physicochemical properties of nanoparticles affect their interaction with transporters and how to optimize the performance of nanoparticle - based drug - delivery systems by adjusting these properties. In addition, the paper also reviews the latest progress in this field in recent years and emphasizes the key factors that need to be considered when developing transporter - assisted nanoparticle - based drug - delivery systems.